课题基金 / 基金详情

New methods for carbon-11 radiotracer synthesis & application to NMDA PET imaging

New methods for carbon-11 radiotracer synthesis & application to NMDA PET imaging
碳11放射性示踪剂合成新方法
批准号:
7673318
负责人:
Jacob M. Hooker
金额:
$0.41万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2009-11-04

项目摘要

项目成果

Jacob M. Hooker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Radiotracers have enabled investigations of molecular phenomena which are at the heart of understanding human disease and developing effective treatments. Yet, there exists a major deficiency in our ability to synthesize radiotracers. The focus of the research described herein is the development of new rapid chemical methods for the incorporation of readily available carbon-11 labeled precursors into common pharmacophore moieties for their use as radiotracers. The strategies are designed to target functional groups that are not adequately addressed by existing carbon-11 incorporation strategies. A particular focus is placed on radiolabeling compounds identified in the literature as candidates for the study and treatment of psychiatric and neurological disorders, with a special emphasis on addictive disorders. Specifically, the new chemical strategies we develop will be used to radiolabel a glutamate receptor antagonist. We will then evaluate the labeled compound as a radiotracer for positron emission tomography (PET).We will accomplish this in three specific aims. In Specific Aim 1, we will develop new rapid chemical reactions for the incorporation of carbon-11 into a) carbamate/carbonate functional groups and b) piperidine heterocycles. This will be accomplished by incorporating common [11C] labeling precursors, [11C]-carbon dioxide and [11C]-cyanide, using rapid organic synthesis. Carbonate and carbamate radiolabeling will be achieved by the direct chemical fixation of [11C]O2. Piperidine heterocycle labeling will be achieved through a novel reductive cyclization of 1,4-cyanoaldehydes prepared from [11C]N. In Specific Aim 2, we will evaluate these chemical strategies by radiolabeling a N-methyl-D-aspartate (NMDA) receptor antagonist. In Specific Aim 3, the radiolabeled antagonist will be evaluated as a radiotracer in vivo by PET. RELEVANCE: Advances in radiotracer chemistry and translational research directed to neurologicall targets involved in human brain dysfunction will accelerate the understanding of brain function and the development of effective treatments for brain disorders. The research proposed herein will advance radiotracer chemistry through the development of new methods for carbon-11 incorporation. These methods will be used for the synthesis of radiotracers to study brain dysfunction & neurological disorders.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/cn9000268
发表时间: 2010
期刊: ACS CHEMICAL NEUROSCIENCE
影响因子: 5
作者: [Hooker, Jacob M., Kim, Sung Won, Alexoff, David, Xu, Youwen, Shea, Colleen, Reid, Alicia, Volkow, Nora, Fowler, Joanna S.]
通讯作者: Fowler, Joanna S.
DOI: 10.1002/anie.200900112
发表时间: 2009
期刊: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子: 16.6
作者: [Hooker, Jacob M., Reibel, Achim T., Hill, Sidney M., Schueller, Michael J., Fowler, Joanna S.]
通讯作者: Fowler, Joanna S.
COX-2-Selective PET Imaging as an Onset Marker of Huntington's Disease
  • 批准号:
    10548808
  • 项目类别:
  • 资助金额:
    $62.04万
  • 财政年份:
    2019
  • 负责人:
    Jacob M. Hooker
  • 依托单位:
COX-2-selective PET imaging as an onset marker of Huntington's disease
  • 批准号:
    9883956
  • 项目类别:
  • 资助金额:
    $66.09万
  • 财政年份:
    2019
  • 负责人:
    Jacob M. Hooker
  • 依托单位:
COX-2-selective PET imaging as an onset marker of Huntington's disease
  • 批准号:
    10308680
  • 项目类别:
  • 资助金额:
    $64.78万
  • 财政年份:
    2019
  • 负责人:
    Jacob M. Hooker
  • 依托单位:
COX-2-selective PET imaging as an onset marker of Huntington's disease
  • 批准号:
    10061659
  • 项目类别:
  • 资助金额:
    $63.52万
  • 财政年份:
    2019
  • 负责人:
    Jacob M. Hooker
  • 依托单位:
海外基金